VEGFA and neovascular glaucoma: The results suggest that anti-VEGF does provide significant IOP lowering in neovascular glaucoma, but similar to our situation where a meta-analysis could not be conducted, the Cochrane review also identified that a meta-analysis could not be carried out because there were very few RCTs with large heterogeneity between them; instead, a narrative synthesis was done, similar to our review.